Alpine Associates Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-96,421
Closed -$10.2M 117
2014
Q2
$10.2M Buy
+96,421
New +$9.46M 0.47% 55

Alpine Associates Advisors's FURX Position: Q3 2014 in Review

Alpine Associates Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 96,421 shares — an estimated $10.2M sold.

Alpine Associates Advisors first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $10.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Alpine Associates Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Alpine Associates Advisors sold 96,421 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $10.2M.
  • Alpine Associates Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Alpine Associates Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $10.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Alpine Associates Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.